miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5

Ovarian cancer is the second most common gynaecological malignancy, and microRNAs (miRNAs) play important role in the cancer development. Here, we found that the level of miR-200b/200a/429 was significantly increased in serum and tumor tissues of patients with stage-I ovarian cancer. Consistent with...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oncology 2020, Vol.2020 (2020), p.1-8
Main Authors: Zou, Hua, Lee, Jin-Won, Chun, Wan Joo, Huang, Ping, Cui, Huiling, Guan, Wei, Kim, Heasung
Format: Article
Language:English
Subjects:
Cancer
Carboplatin
Cell culture
Cell growth
Comparative analysis
Development and progression
Diagnosis
Experiments
Gene expression
Metastasis
MicroRNA
MicroRNAs
Ovarian cancer
Patients
Protein expression
Proteins
Tumorigenesis
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c565t-4ab28349b3520f525831fd1e08000416294fa99ebd45ebdfcedcd7ce9b9085b03
cites cdi_FETCH-LOGICAL-c565t-4ab28349b3520f525831fd1e08000416294fa99ebd45ebdfcedcd7ce9b9085b03
container_end_page 8
container_issue 2020
container_start_page 1
container_title Journal of oncology
container_volume 2020
creator Zou, Hua
Lee, Jin-Won
Chun, Wan Joo
Huang, Ping
Cui, Huiling
Guan, Wei
Kim, Heasung
description Ovarian cancer is the second most common gynaecological malignancy, and microRNAs (miRNAs) play important role in the cancer development. Here, we found that the level of miR-200b/200a/429 was significantly increased in serum and tumor tissues of patients with stage-I ovarian cancer. Consistent with these results, we detected increased expression levels of miR-200b/200a/429 in ovarian cancer cell lines compared with the human nontumorigenic ovarian epithelial cell line T80. The overexpression of miR-200b/200a/429 in T80 cells stimulated proliferation and caused their growth in soft agar and tumor formation in nude mice. Furthermore, we determined that miR-200b/200a/429 targets inhibitor of growth family 5 (ING5) and that the overexpression of ING5 can block miR-200b/200a/429-induced T80 cell transformation and tumorigenesis. Our findings suggest that miR-200b/200a/429 may be a useful biomarker for the early detection of ovarian cancer and that miR-200b/200a/429 significantly contributes to ovarian cancer development through ING5.
doi_str_mv 10.1155/2020/3404059
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7193301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A627596641</galeid><sourcerecordid>A627596641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-4ab28349b3520f525831fd1e08000416294fa99ebd45ebdfcedcd7ce9b9085b03</originalsourceid><addsrcrecordid>eNqNkU1v1DAURa0K1JbCrmsUiU0lSOf5K7E3laoBSqWKCmjXlpO8TF0lztROBvXf42GGMrDqxrb0jo7f1SXkmMIppVLOGDCYcQECpN4jh7RQZa6EhBc77wPyKsZ7gEKALvbJAWe8LKmmh-Rb777nDKBKHrAzwXQ276Y4Ysh-jK6fOjtizK5XNjjrs7n1dZp8xBV2w7JHP2bVY3ZjwwJH5xfZ5dcL-Zq8bG0X8c32PiK3nz_dzL_kV9cXl_Pzq7yWhRxzYSumuNAVlwxayaTitG0oggIAQQumRWu1xqoRMh1tjU3dlDXqSoOSFfAjcrbxLqeqT8O0TLCdWQbX2_BoBuvMvxPv7sxiWJkUnHOgSXCyFYThYcI4mt7FGrvOehymaBjXWvFSiTX67j_0fpiCT_EMExRKqhjdoRa2Q-N8O6R_67XUnBeslLoofrs-bKg6DDEGbJ9WpmDWjZp1o2bbaMLf7sZ8gv9UmID3G-DO-cb-dM_UYWKwtX9pqpTSmv8CRsqunQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2410718211</pqid></control><display><type>article</type><title>miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Open Access</source><creator>Zou, Hua ; Lee, Jin-Won ; Chun, Wan Joo ; Huang, Ping ; Cui, Huiling ; Guan, Wei ; Kim, Heasung</creator><contributor>Izadpanah, Reza ; Reza Izadpanah</contributor><creatorcontrib>Zou, Hua ; Lee, Jin-Won ; Chun, Wan Joo ; Huang, Ping ; Cui, Huiling ; Guan, Wei ; Kim, Heasung ; Izadpanah, Reza ; Reza Izadpanah</creatorcontrib><description>Ovarian cancer is the second most common gynaecological malignancy, and microRNAs (miRNAs) play important role in the cancer development. Here, we found that the level of miR-200b/200a/429 was significantly increased in serum and tumor tissues of patients with stage-I ovarian cancer. Consistent with these results, we detected increased expression levels of miR-200b/200a/429 in ovarian cancer cell lines compared with the human nontumorigenic ovarian epithelial cell line T80. The overexpression of miR-200b/200a/429 in T80 cells stimulated proliferation and caused their growth in soft agar and tumor formation in nude mice. Furthermore, we determined that miR-200b/200a/429 targets inhibitor of growth family 5 (ING5) and that the overexpression of ING5 can block miR-200b/200a/429-induced T80 cell transformation and tumorigenesis. Our findings suggest that miR-200b/200a/429 may be a useful biomarker for the early detection of ovarian cancer and that miR-200b/200a/429 significantly contributes to ovarian cancer development through ING5.</description><identifier>ISSN: 1687-8450</identifier><identifier>EISSN: 1687-8450</identifier><identifier>EISSN: 1687-8469</identifier><identifier>DOI: 10.1155/2020/3404059</identifier><identifier>PMID: 32377191</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Cancer ; Carboplatin ; Cell culture ; Cell growth ; Comparative analysis ; Development and progression ; Diagnosis ; Experiments ; Gene expression ; Metastasis ; MicroRNA ; MicroRNAs ; Ovarian cancer ; Patients ; Protein expression ; Proteins ; Tumorigenesis ; Tumors</subject><ispartof>Journal of oncology, 2020, Vol.2020 (2020), p.1-8</ispartof><rights>Copyright © 2020 Wei Guan et al.</rights><rights>COPYRIGHT 2020 John Wiley &amp; Sons, Inc.</rights><rights>Copyright © 2020 Wei Guan et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2020 Wei Guan et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-4ab28349b3520f525831fd1e08000416294fa99ebd45ebdfcedcd7ce9b9085b03</citedby><cites>FETCH-LOGICAL-c565t-4ab28349b3520f525831fd1e08000416294fa99ebd45ebdfcedcd7ce9b9085b03</cites><orcidid>0000-0003-4605-4015 ; 0000-0001-5491-7533</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2410718211/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2410718211?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,25753,27923,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32377191$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Izadpanah, Reza</contributor><contributor>Reza Izadpanah</contributor><creatorcontrib>Zou, Hua</creatorcontrib><creatorcontrib>Lee, Jin-Won</creatorcontrib><creatorcontrib>Chun, Wan Joo</creatorcontrib><creatorcontrib>Huang, Ping</creatorcontrib><creatorcontrib>Cui, Huiling</creatorcontrib><creatorcontrib>Guan, Wei</creatorcontrib><creatorcontrib>Kim, Heasung</creatorcontrib><title>miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5</title><title>Journal of oncology</title><addtitle>J Oncol</addtitle><description>Ovarian cancer is the second most common gynaecological malignancy, and microRNAs (miRNAs) play important role in the cancer development. Here, we found that the level of miR-200b/200a/429 was significantly increased in serum and tumor tissues of patients with stage-I ovarian cancer. Consistent with these results, we detected increased expression levels of miR-200b/200a/429 in ovarian cancer cell lines compared with the human nontumorigenic ovarian epithelial cell line T80. The overexpression of miR-200b/200a/429 in T80 cells stimulated proliferation and caused their growth in soft agar and tumor formation in nude mice. Furthermore, we determined that miR-200b/200a/429 targets inhibitor of growth family 5 (ING5) and that the overexpression of ING5 can block miR-200b/200a/429-induced T80 cell transformation and tumorigenesis. Our findings suggest that miR-200b/200a/429 may be a useful biomarker for the early detection of ovarian cancer and that miR-200b/200a/429 significantly contributes to ovarian cancer development through ING5.</description><subject>Cancer</subject><subject>Carboplatin</subject><subject>Cell culture</subject><subject>Cell growth</subject><subject>Comparative analysis</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Experiments</subject><subject>Gene expression</subject><subject>Metastasis</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>Ovarian cancer</subject><subject>Patients</subject><subject>Protein expression</subject><subject>Proteins</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><issn>1687-8450</issn><issn>1687-8450</issn><issn>1687-8469</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNkU1v1DAURa0K1JbCrmsUiU0lSOf5K7E3laoBSqWKCmjXlpO8TF0lztROBvXf42GGMrDqxrb0jo7f1SXkmMIppVLOGDCYcQECpN4jh7RQZa6EhBc77wPyKsZ7gEKALvbJAWe8LKmmh-Rb777nDKBKHrAzwXQ276Y4Ysh-jK6fOjtizK5XNjjrs7n1dZp8xBV2w7JHP2bVY3ZjwwJH5xfZ5dcL-Zq8bG0X8c32PiK3nz_dzL_kV9cXl_Pzq7yWhRxzYSumuNAVlwxayaTitG0oggIAQQumRWu1xqoRMh1tjU3dlDXqSoOSFfAjcrbxLqeqT8O0TLCdWQbX2_BoBuvMvxPv7sxiWJkUnHOgSXCyFYThYcI4mt7FGrvOehymaBjXWvFSiTX67j_0fpiCT_EMExRKqhjdoRa2Q-N8O6R_67XUnBeslLoofrs-bKg6DDEGbJ9WpmDWjZp1o2bbaMLf7sZ8gv9UmID3G-DO-cb-dM_UYWKwtX9pqpTSmv8CRsqunQ</recordid><startdate>2020</startdate><enddate>2020</enddate><creator>Zou, Hua</creator><creator>Lee, Jin-Won</creator><creator>Chun, Wan Joo</creator><creator>Huang, Ping</creator><creator>Cui, Huiling</creator><creator>Guan, Wei</creator><creator>Kim, Heasung</creator><general>Hindawi Publishing Corporation</general><general>Hindawi</general><general>John Wiley &amp; Sons, Inc</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4605-4015</orcidid><orcidid>https://orcid.org/0000-0001-5491-7533</orcidid></search><sort><creationdate>2020</creationdate><title>miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5</title><author>Zou, Hua ; Lee, Jin-Won ; Chun, Wan Joo ; Huang, Ping ; Cui, Huiling ; Guan, Wei ; Kim, Heasung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-4ab28349b3520f525831fd1e08000416294fa99ebd45ebdfcedcd7ce9b9085b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cancer</topic><topic>Carboplatin</topic><topic>Cell culture</topic><topic>Cell growth</topic><topic>Comparative analysis</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Experiments</topic><topic>Gene expression</topic><topic>Metastasis</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>Ovarian cancer</topic><topic>Patients</topic><topic>Protein expression</topic><topic>Proteins</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zou, Hua</creatorcontrib><creatorcontrib>Lee, Jin-Won</creatorcontrib><creatorcontrib>Chun, Wan Joo</creatorcontrib><creatorcontrib>Huang, Ping</creatorcontrib><creatorcontrib>Cui, Huiling</creatorcontrib><creatorcontrib>Guan, Wei</creatorcontrib><creatorcontrib>Kim, Heasung</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zou, Hua</au><au>Lee, Jin-Won</au><au>Chun, Wan Joo</au><au>Huang, Ping</au><au>Cui, Huiling</au><au>Guan, Wei</au><au>Kim, Heasung</au><au>Izadpanah, Reza</au><au>Reza Izadpanah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5</atitle><jtitle>Journal of oncology</jtitle><addtitle>J Oncol</addtitle><date>2020</date><risdate>2020</risdate><volume>2020</volume><issue>2020</issue><spage>1</spage><epage>8</epage><pages>1-8</pages><issn>1687-8450</issn><eissn>1687-8450</eissn><eissn>1687-8469</eissn><abstract>Ovarian cancer is the second most common gynaecological malignancy, and microRNAs (miRNAs) play important role in the cancer development. Here, we found that the level of miR-200b/200a/429 was significantly increased in serum and tumor tissues of patients with stage-I ovarian cancer. Consistent with these results, we detected increased expression levels of miR-200b/200a/429 in ovarian cancer cell lines compared with the human nontumorigenic ovarian epithelial cell line T80. The overexpression of miR-200b/200a/429 in T80 cells stimulated proliferation and caused their growth in soft agar and tumor formation in nude mice. Furthermore, we determined that miR-200b/200a/429 targets inhibitor of growth family 5 (ING5) and that the overexpression of ING5 can block miR-200b/200a/429-induced T80 cell transformation and tumorigenesis. Our findings suggest that miR-200b/200a/429 may be a useful biomarker for the early detection of ovarian cancer and that miR-200b/200a/429 significantly contributes to ovarian cancer development through ING5.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>32377191</pmid><doi>10.1155/2020/3404059</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4605-4015</orcidid><orcidid>https://orcid.org/0000-0001-5491-7533</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1687-8450
ispartof Journal of oncology, 2020, Vol.2020 (2020), p.1-8
issn 1687-8450
1687-8450
1687-8469
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7193301
source Open Access: PubMed Central; Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Open Access
subjects Cancer
Carboplatin
Cell culture
Cell growth
Comparative analysis
Development and progression
Diagnosis
Experiments
Gene expression
Metastasis
MicroRNA
MicroRNAs
Ovarian cancer
Patients
Protein expression
Proteins
Tumorigenesis
Tumors
title miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A19%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-200b/200a/429%20Cluster%20Stimulates%20Ovarian%20Cancer%20Development%20by%20Targeting%20ING5&rft.jtitle=Journal%20of%20oncology&rft.au=Zou,%20Hua&rft.date=2020&rft.volume=2020&rft.issue=2020&rft.spage=1&rft.epage=8&rft.pages=1-8&rft.issn=1687-8450&rft.eissn=1687-8450&rft_id=info:doi/10.1155/2020/3404059&rft_dat=%3Cgale_pubme%3EA627596641%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c565t-4ab28349b3520f525831fd1e08000416294fa99ebd45ebdfcedcd7ce9b9085b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2410718211&rft_id=info:pmid/32377191&rft_galeid=A627596641&rfr_iscdi=true